{"id":"https://genegraph.clinicalgenome.org/r/0fee5c0d-acfc-469c-9c75-0c4a9703ea3ev1.0","type":"EvidenceStrengthAssertion","dc:description":"OSBPL2 was reported with autosomal dominant nonsyndromic hearing loss in 2015 (Xing et al., PMID: 25077649). At least 4 unique variants (missense, frameshift) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Variants in this gene have been reported in at least 4 probands in 3 publications (PMID: 25077649, 25759012, 30894143). Variants in this gene segregated with disease in 31 additional family members. This gene-disease association is supported by animal models and expression studies. In summary, there is moderate evidence to support this gene-disease association. While more evidence is needed to establish this association definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Hearing Loss Working Group on 2/6/2020.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/0fee5c0d-acfc-469c-9c75-0c4a9703ea3e","GCISnapshot":"https://genegraph.clinicalgenome.org/r/a493a4c4-3a9f-431a-a68e-d90d9a11b6f0","calculatedEvidenceStrength":"Moderate","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/a493a4c4-3a9f-431a-a68e-d90d9a11b6f0_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10007","date":"2020-02-06T17:20:31.658Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/a493a4c4-3a9f-431a-a68e-d90d9a11b6f0_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10007","date":"2020-09-01T00:00:00Z","role":"Publisher"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a493a4c4-3a9f-431a-a68e-d90d9a11b6f0_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a493a4c4-3a9f-431a-a68e-d90d9a11b6f0_ad_null_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fb22e57b-c6bd-4f89-920c-3f39567412ad_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Family was of German descent. One additional 39 y-o family member (IV:12) carried the variant but only reports worse hearing in times of stress. Not included in segregation count. No evidence provided for LoF, so downgraded to 1","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fb53805b-4b14-46b4-96e5-34a8f54a53d9","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25759012","rdfs:label":"Theones 1 Proband","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","phenotypeFreeText":"bilateral sensorineural hearing loss, mostly with onset in early second decade of life, however age of onset varied between 10 and 30. Generally varied progression.","phenotypes":"obo:HP_0000408","previousTesting":true,"previousTestingDescription":"GJB2 negative, and negative for 66 known deafness genes.","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/fb22e57b-c6bd-4f89-920c-3f39567412ad_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25759012","allele":{"id":"https://genegraph.clinicalgenome.org/r/6d047b8e-258b-40ea-a9cb-f255242c5234","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_144498.2(OSBPL2):c.141_142delTG (p.Arg50Alafs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/190111"}}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/844cf61a-e9e9-4664-a090-71ae3f374993_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Family was of Han Chinese descent. Pedigree spanned 7 generations and included 199 members. 45 living members reported to have HL, with 25 available for study. 26 unaffected members were available for study. Maxed segregation points.Â WES","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/62f484e2-fcc8-4646-80fb-394d3467e87b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25077649","rdfs:label":"Xing-1 Proband","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"bilateral, mild to profound sensorineural hearing loss. Usually startd at high frequencies at an early age and progressed rapidly to other frequencies at a later age. All but one reported high-frequency tinnitus around onset of HL. No vestibular symptoms. Age of onset varied from 5 to 32 years. Full clinical data available in supp. material","phenotypes":["obo:HP_0000408","obo:HP_0000360"],"previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/844cf61a-e9e9-4664-a090-71ae3f374993_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25077649","allele":{"id":"https://genegraph.clinicalgenome.org/r/8017f42a-9fd4-45f8-9464-4944596d63be","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_144498.2(OSBPL2):c.156_157delTC (p.Gln53Argfs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/190110"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/9d7e069c-250a-419c-9683-eaa1bb62e418_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Scored 2 points and upgraded due to segregation in large family in a relatively constrained gene. Remaining consistent with upgrade of previous null variant in Xing 2015","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6a8970ca-a70a-4fd3-bcf4-e7900235038e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30894143","rdfs:label":"V:9","ageType":"AgeAtReport","ageUnit":"Years","ageValue":44,"detectionMethod":"WGS performed on 5 members of the family (3 affected and 2 unaffected). Sanger sequencing used to validate the co-segregation of the candidate pathogenic variant. Linkage analysis also performed using Perl based Merlin tools and combined high throughput sequencing data in the family and allelic frequency of Chinese population in HapMap database. All SNPs and indels were filtered through the 1000 Genomes Project and candidate genes were further screened. The results were screened by in house Novogene algorithm and combined with dbSNP, ExAC. This narrowed it down to OSBPL2 and matched the localization and was consistent with the peak detected in chromosome 20 in the linkage analysis.","firstTestingMethod":"Whole genome shotgun sequencing","phenotypeFreeText":"moderate SNHL","phenotypes":["obo:HP_0008596","obo:HP_0001730"],"previousTesting":true,"previousTestingDescription":"Exome capture sequencing on 127 known deafness genes failed to identify any pathogenic mutations","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/9d7e069c-250a-419c-9683-eaa1bb62e418_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30894143","allele":{"id":"https://genegraph.clinicalgenome.org/r/35fc2f02-c1ca-42fd-907d-82bec0cf65dc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001363878.1(OSBPL2):c.-209_-208del (p.=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA915940532"}}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallAutosomalDominantNullVariantEvidenceCriteria","strengthScore":5},{"id":"https://genegraph.clinicalgenome.org/r/a493a4c4-3a9f-431a-a68e-d90d9a11b6f0_ad_other_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/46ebda13-5443-4c02-830a-7737bdaf4703_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Proband was identified upon screening of 452 sporadic NSHL cases. Computational modeling predicts a change of shape to the protein in the predicted ligand-binding domain. No score","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1759ce0a-c93a-42e6-af17-f8c7cb2fc79f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25077649","rdfs:label":"Xing-2","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","phenotypeFreeText":"bilateral symmetric moderate sensorineural hearing loss","phenotypes":"obo:HP_0000408","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/46ebda13-5443-4c02-830a-7737bdaf4703_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25077649","allele":{"id":"https://genegraph.clinicalgenome.org/r/003e110a-69cb-4d57-a6df-b56f3e41582e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000020.11:g.62279248C>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA409542766"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/a493a4c4-3a9f-431a-a68e-d90d9a11b6f0_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ae6af483-d5d9-4519-a389-63676000e2c8_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25077649","rdfs:label":"Xing-1","estimatedLodScore":7.22,"family":{"id":"https://genegraph.clinicalgenome.org/r/ae6af483-d5d9-4519-a389-63676000e2c8","type":"Family","rdfs:label":"Xing-1","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/62f484e2-fcc8-4646-80fb-394d3467e87b"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"bilateral, mild to profound sensorineural hearing loss. Usually startd at high frequencies at an early age and progressed rapidly to other frequencies at a later age. All but one reported high-frequency tinnitus around onset of HL. No vestibular symptoms. Age of onset varied from 5 to 32 years. Full clinical data available in supp. material","phenotypeNegativeAlleleNegative":26,"phenotypePositiveAllelePositive":25,"phenotypes":"obo:HP_0000408","proband":{"id":"https://genegraph.clinicalgenome.org/r/62f484e2-fcc8-4646-80fb-394d3467e87b"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/6ab07e3e-3d1a-4593-be7d-9578eb2b13ff_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30894143","rdfs:label":"Wu Family","estimatedLodScore":1.81,"family":{"id":"https://genegraph.clinicalgenome.org/r/6ab07e3e-3d1a-4593-be7d-9578eb2b13ff","type":"Family","rdfs:label":"Wu Family","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/6a8970ca-a70a-4fd3-bcf4-e7900235038e"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"delayed hearing loss with the age of onset between 10-40 years old and history of tinnitus but no vestibule dysfunction; no history of ototoxic drug use, noise exposure, or mental disorders; all hearing loss was post lingual with increasing severity with age; hearing tests diagnosed as bilaterally symmetric, mild to severe SNHL (Fig 2.); normal tympanometry","phenotypePositiveAllelePositive":7,"phenotypes":["obo:HP_0001730","obo:HP_0008596"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/6a8970ca-a70a-4fd3-bcf4-e7900235038e"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/677e716e-f392-4da0-a892-b612f29eb7ab_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25759012","rdfs:label":"Theones 1 Family","estimatedLodScore":2.11,"family":{"id":"https://genegraph.clinicalgenome.org/r/677e716e-f392-4da0-a892-b612f29eb7ab","type":"Family","rdfs:label":"Theones 1 Family","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/fb53805b-4b14-46b4-96e5-34a8f54a53d9"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"bilateral sensorineural hearing loss, mostly with onset in early second decade of life, however age of onset varied between 10 and 30. Generally varied progression.","phenotypeNegativeAlleleNegative":6,"phenotypePositiveAllelePositive":8,"phenotypes":"obo:HP_0000408","proband":{"id":"https://genegraph.clinicalgenome.org/r/fb53805b-4b14-46b4-96e5-34a8f54a53d9"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":8},{"id":"https://genegraph.clinicalgenome.org/r/a493a4c4-3a9f-431a-a68e-d90d9a11b6f0_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a493a4c4-3a9f-431a-a68e-d90d9a11b6f0_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9e268618-6a34-4173-8016-3b5584deb30c","type":"EvidenceLine","dc:description":"The pig model was a homozygous knockout model not heterozygous even though this has been associated with a heterozygous condition.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/00458f7a-328f-47b1-8914-0f684272cff6","type":"Finding","dc:description":"Both humans and pigs exhibit similar types and levels of hearing loss. This also confirms the dual phenotypes seen in humans with mutations in OSBPL2 (progressive hearing loss and hypercholesterolemia).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31451425","rdfs:label":"Bama miniature pig model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/a493a4c4-3a9f-431a-a68e-d90d9a11b6f0_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e5128ace-d1ad-40a9-97d8-657408a2d7ca","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7240fb87-f731-4355-8438-29e6c897fd55","type":"Finding","dc:description":"RT-PCR revealed strong expresson of OSBPL2 in mouse cochlea (as well as brain). Immunohistochemical localization showed Osbpl2 in the stria vascularis, spiral ganglion, IHCs and OHCs of mouse cochlea.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25077649","rdfs:label":"Xing-expression (inner ear)","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9e8d82d0-49ef-4671-8ffe-86a2ab09df68","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/901dc35d-22c5-46f8-82da-8e1b96a9e7fe","type":"Finding","dc:description":"RT-PCR of mouse and rat cochlea showed presence of OSBPL2 transcript in both. Immunofluorescent staining of mouse organ of Corti showed Osbpl2 present in both OHCs and IHCs. No difference was found in Osbpl2 levels between P20 and 6 month old mice.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25759012","rdfs:label":"Mouse and rat cochlea expression","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2}],"evidenceStrength":"Moderate","sequence":283,"specifiedBy":"GeneValidityCriteria7","strengthScore":10,"subject":{"id":"https://genegraph.clinicalgenome.org/r/w7FmBQNLeXc","type":"GeneValidityProposition","disease":"obo:MONDO_0019497","gene":"hgnc:15761","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_a493a4c4-3a9f-431a-a68e-d90d9a11b6f0-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}